Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma

被引：0
|
作者：
Kröger, N
Shimoni, A
Zagrivnaja, M
Ayuk, F
Lioznov, M
Schieder, H
Renges, H
Fehse, B
Zabelina, T
Nagler, A
Zander, A
机构：
[1] Zander Univ, Hosp Hamburg, Hamburg, Germany
[2] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [41] Prolonged Repeatedly Administered Low Dose Donor Lymphocyte Infusion for Prevention of Relapse After Allogeneic Stem Cell Transplantation for Patients With High Risk Acute Leukemia
    Tsirigotis, Panagiotis
    Stamouli, Maria
    Gkirkas, Konstantinos
    Karagiannidou, Angeliki
    Chondropoulos, Spiros
    Nagler, Arnon
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 199 - 200
  • [42] Treatments of disease relapse after allogeneic stem cell transplantation focusing on donor lymphocyte infusion
    Liu Hong-tao
    Liu Dai-hong
    Huang Xiao-jun
    Artz, Andrew
    Bishop, Michael R.
    CHINESE MEDICAL JOURNAL, 2013, 126 (22) : 4380 - 4388
  • [43] Treatments of disease relapse after allogeneic stem cell transplantation focusing on donor lymphocyte infusion
    LIU Hong-tao
    LIU Dai-hong
    HUANG Xiao-jun
    rew Artz
    Michael R.Bishop
    中华医学杂志(英文版), 2013, 126 (22) : 4380 - 4388
  • [44] DONOR LYMPHOCYTE INFUSION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN CHILDREN: SINGLE CENTER EXPERIENCE
    Park, J. E.
    Lee, K. C.
    Jung, H. J.
    Lee, S. W.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S494 - S494
  • [45] Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplant
    Beitinjaneh, Amer M.
    Saliba, Rima
    Bashir, Qaiser
    Shah, Nina
    Parmar, Simrit
    Hosing, Chitara
    Popat, Uday
    Anderlini, Paolo
    Dinh, Yvonne
    Qureshi, Sofia
    Rondon, Gabriela
    Champlin, Richard E.
    Giralt, Sergio A.
    Qazilbash, Muzaffar H.
    LEUKEMIA & LYMPHOMA, 2012, 53 (08) : 1525 - 1529
  • [46] Salvage of multiple myeloma patients relapse after an autologous stem cell transplantation, in the era of thalidomide and reduced-intensity allogeneic stem cell transplantation
    Hardan, I
    Kneller, A
    Shimoni, A
    Berkowicz, M
    Avigdor, A
    Yeshurun, M
    Raanani, P
    Davidowich, Y
    Shemtov, N
    Ben Bassat, I
    Nagler, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S156 - S157
  • [47] Association of higher total nucleated cell dose with improved survival in patients receiving donor lymphocyte infusion after allogeneic stem cell transplantation.
    Singh, Nathan
    Kumar, Anita J.
    Gao, Amy
    Luskin, Marlise Rachael
    Frey, Noelle V.
    Hexner, Elizabeth O.
    Loren, Alison W.
    Luger, Selina M.
    Stadtmauer, Edward Allen
    Porter, David L.
    Reshef, Ran
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] Efficacy and toxicity profiles of low-dose thalidomide as maintenance therapy in multiple myeloma patients after double or triple autologous peripheral blood stem cell transplantation
    Morabito, F
    Martino, M
    Console, G
    Galimberti, S
    Messina, G
    Irrera, G
    Pucci, G
    Cuzzola, M
    Petrini, M
    Iacopino, P
    BONE MARROW TRANSPLANTATION, 2005, 35 : S252 - S253
  • [49] Donor lymphocyte infusion to enhance remission status post allogeneic stem cell transplantation in patients with multiple myeloma who did not achieve complete remission
    Petersen, L.
    Ayuk, F.
    Bacher, U.
    Wolschke, C.
    Zander, A. R.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S323 - S323
  • [50] Adoptive immunotherapy ± Ruxolitinib and second allogeneic hematopoietic stem cell transplantation in patients with relapsed Myelofibrosis after allogeneic hematopoietic stem cell transplantation
    Bogdanov, R.
    Ditschkowski, M.
    Steckel, N. -K.
    Klisanin, V.
    Kordelas, L.
    Trenschel, R.
    Beelen, D. W.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 60 - 61
12345